Glycogenoses

Citations 1-10 of 12 total displayed.

Most recent content (24 Feb 2009):

ARTICLES
Fat metabolism during exercise in patients with McArdle disease: M. C. Ørngreen, T. D. Jeppesen, S. Tvede Andersen, T. Taivassalo, S. Hauerslev, N. Preisler, R. G. Haller, G. van Hall, and J. Vissing
Neurology 2009; 72: 718-724. [Abstract] [Full text] [PDF]

Past content (since Aug 2002):

ARTICLES
Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease: P. Laforêt, P. Petiot, M. Nicolino, D. Orlikowski, C. Caillaud, N. Pellegrini, R. Froissart, T. Petitjean, I. Maire, H. Chabriat, L. Hadrane, D. Annane, and B. Eymard
Neurology 2008; 70: 2063-2066. [Abstract] [Full text] [PDF]

CLINICAL/SCIENTIFIC NOTES
EXTRACEPHALIC CLUSTER (CLUSTER SINE HEADACHE): Esma Dilli and David W. Dodick
Neurology 2008; 70: 1362-1363. [Full text] [PDF]

EDITORIALS
Enzyme replacement for infantile Pompe disease: The first step toward a cure: Kathryn R. Wagner
Neurology 2007; 68: 88-89. [Full text] [PDF]

ARTICLES
Recombinant human acid ${alpha}$ -glucosidase: Major clinical benefits in infantile-onset Pompe disease: P. S. Kishnani, D. Corzo, M. Nicolino, B. Byrne, H. Mandel, W. L. Hwu, N. Leslie, J. Levine, C. Spencer, M. McDonald, J. Li, J. Dumontier, M. Halberthal, Y. H. Chien, R. Hopkin, S. Vijayaraghavan, D. Gruskin, D. Bartholomew, A. van der Ploeg, J. P. Clancy, R. Parini, G. Morin, M. Beck, G. S. De la Gastine, M. Jokic, B. Thurberg, S. Richards, D. Bali, M. Davison, M. A. Worden, Y. T. Chen, and J. E. Wraith
Neurology 2007; 68: 99-109. [Abstract] [Full text] [PDF]

CLINICAL/SCIENTIFIC NOTES
Ptosis as a feature of late-onset glycogenosis type II: W. B. Groen, W. G. Leen, A.M.C. Vos, J. R.M. Cruysberg, P. A. van Doorn, and B. G.M. van Engelen
Neurology 2006; 67: 2261-2262. [Full text] [PDF]

BRIEF COMMUNICATIONS
Do carriers of PYGM mutations have symptoms of McArdle disease?: Susanne Tvede Andersen, Morten Dunø, Marianne Schwartz, and John Vissing
Neurology 2006; 67: 716-718. [Abstract] [Full text] [PDF]

BRIEF COMMUNICATIONS
Disease severity in children and adults with Pompe disease related to age and disease duration: M.L.C. Hagemans, L. P.F. Winkel, W. C.J. Hop, A. J.J. Reuser, P. A. Van Doorn, and A. T. Van der Ploeg
Neurology 2005; 64: 2139-2141. [Abstract] [Full text] [PDF]

ARTICLES
Late-onset Pompe disease primarily affects quality of life in physical health domains: M. L.C. Hagemans, A. C.J.W. Janssens, L. P.F. Winkel, K. A. Sieradzan, A. J.J. Reuser, P. A. Van Doorn, and A. T. Van der Ploeg
Neurology 2004; 63: 1688-1692. [Abstract] [Full text] [PDF]

BRIEF COMMUNICATIONS
A neonatal form of glycogen storage disease type IV: M. Nambu, K. Kawabe, T. Fukuda, T. B. Okuno, S. Ohta, I. Nonaka, H. Sugie, and I. Nishino
Neurology 2003; 61: 392-394. [Abstract] [Full text] [PDF]

Collected Resources Home

HOME